It has to be stressed that we propose to use [111In]In-DOTA-HE3-ZCAIX:2 first and foremost for detection of CAIX expression in known RCC metastases for selection of patients for CAIX-targeting treatment, but not for detection of metastatic RCC. Here, CA9 is linked to renal cell carcinoma.